Artículo original
Mutaciones en el gen de la cadena pesada de la betamiosina en pacientes con miocardiopatía hipertróficaBeta-Myosin Heavy-Chain Gene Mutations in Patients With Hypertrophic Cardiomyopathy

https://doi.org/10.1157/13093977Get rights and content

Introducción y objetivos

Determinar la frecuencia de mutaciones en el gen de la cadena pesada de la betamiosina (MYH7) en una cohorte de pacientes con miocardiopatía hipertrófica (MCH) y en sus familiares, y analizar la correlación entre genotipo y fenotipo.

Métodos

Detección de polimorfismo en la conformación de hebras monocatenarias y secuenciación de fragmentos con movilidad anormal del gen MYH7 en 128 casos índice consecutivos con MCH. Comparación de fenotipo entre pacientes con y sin mutaciones y descripción del fenotipo de las familias identificadas.

Resultados

Identificamos 11 mutaciones en 13 familias (10%), 7/11 previamente descritas. La mutación I736T se identificó en 3 familias y la A797T en 2. Un caso presentó 2 mutaciones (I736T y R787H). Las mutaciones fueron más frecuentes en pacientes con antecedentes familiares de muerte súbita (31%) y con hipertrofia severa (39% con grosor ≥ 30 mm). Había mutación en 29 de 42 miembros de las 13 familias, incluidos 6 (20%) portadores sanos (edad ≤ 36 años). Había antecedentes de muerte súbita en 9 familiares de 4 familias (4 en 2 familias con I736T, uno con A797T, uno con R870H y 2 con A901P).

Conclusiones

Las mutaciones en MYH7 aparecen en un 10% de nuestras familias y son más frecuentes cuando hay antecedentes familiares de muerte súbita o hipertrofia severa. La mayor parte había sido descrita previamente y algunas se repiten en varias familias. Ciertas mutaciones muestran una correlación genotipo-fenotipo estable, mientras que en otras, las marcadas diferencias entre casos índice y familiares hacen sospechar la presencia de factores genéticos adicionales que debemos identificar.

Introduction and objectives

To determine the frequency of mutations in the beta-myosin heavy-chain gene (MYH7) in a cohort of patients with hypertrophic cardiomyopathy (HCM) and their families, and to investigate correlations between genotype and phenotype

Methods

Single-strand conformation polymorphism analysis and sequencing of fragments with abnormal MYH7 gene mobility were carried out in 128 consecutive index patients with HCM. The phenotypes of patients with and without mutations were compared and the phenotypes of identified families were recorded.

Results

A total of 11 mutations were found in 13 families (10%); 7/11 had been previously described. The I736T mutation was found in three families and the A797T in two. One patient had two mutations (i.e., I736T and R787H). Mutations were more frequent in patients with a family history of sudden death (31%) and in those with severe hypertrophy (39% had a thickness ≥30 mm). Mutations were found in 29 of 42 members of the 13 families, including six family members (20%) who were healthy carriers and aged ≤36 years. Sudden death had occurred in eight members of four families: four in two families with the I736T mutation, one in a family with A797T, one in a family with R870H, and two in a family with A901P.

Conclusions

MYH7 mutations were present in 10% of our families. Mutations were more frequent in patients with a family history of sudden death and in those with severe hypertrophy. Most mutations had been described previously. Some appeared in several families. For some mutations, the correlation between genotype and phenotype was stable, while for others, there were marked differences between the phenotypes of the index patients and their relatives, suggesting the presence of additional genetic factors that have yet to be identified.

Bibliografía (38)

  • I. Olivotto et al.

    Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy

    J Am Coll Cardiol

    (2005)
  • Report of the 1995 World Health Organization. International Society and Federation of Cardiology Task Force on the...
  • B.J. Maron et al.

    ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy)

    Eur Heart J

    (2003)
  • A.J. Marian et al.

    Recent advances in the molecular genetics of hypertrophic cardiomyopathy

    Circulation

    (1995)
  • R. Roberts et al.

    New concepts in hypertrophic cardiomyopathies, part I

    Circulation

    (2001)
  • A. Kimura et al.

    Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

    Nat Genet

    (1997)
  • P. Spirito et al.

    The management of hypertrophic cardiomyopathy

    N Engl J Med

    (1997)
  • P. Richard et al.

    Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

    Circulation

    (2003)
  • S.L. Driest et al.

    Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy

    J Am Coll Cardiol

    (2004)
  • Cited by (0)

    View full text